Skip to main content
. 2018 Jul 16;13(7):e0199529. doi: 10.1371/journal.pone.0199529

Table 12. Summary of EORCT and PERCIST evaluation methods.

EORTC PERCIST
Measurable parameters/lesions    
Measurable lesion (threshold definition) Viable tumor (SUV> surrounding background) SULpeak >1.5 liver SULmean + 2DS
Target lesions Viable tumors; no number given (5 in study) Highest SULpeak lesion (1 lesion)
Measured parameter for metabolic response evaluation ΔΣSUVmax target lesions ΔΣSULpeak target lesion
Response criteria    
CMR No viable tumor No lesion above > threshold
PMR Reduction of minimum of 25% in ΔΣSUVmax Reduction of minimum of 30% in target measurable tumor 18F-FDG SUL peak
SMD Not CMR, PMD or PMR Not CMR, PMD or PMR
PMD Increase in ΔΣSUVmax >25% or new lesion Increase in SULpeak >30% or new lesion

EORTC = European Organization for Research and Treatment of Cancer; PERCIST = PET Response Criteria in solid Tumours; CMR = Complete metabolic response; PMR = Partial metabolic response; SMD = Stable metabolic disease; PMD = Progressive metabolic disease